MetLife, Inc. MET
97.70
0.45
0.46%
as of 25 Sep
- Market cap
- $61.6B
- P/E
- 18.7×
Follow MET
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 12.36% | 12.41% | 11.26% | 12.04% |
+8 more TTM periods Free account |
|
| 0.47% | 0.48% | 0.45% | 0.51% | ||
ROIC |
10.65% | 11.94% | 11.21% | 10.55% | |
Return on Tangible Assets |
(0.84%) | (0.85%) | (0.79%) | (0.91%) | |
Average Days of Receivables |
234.72 | 238.93 | 235.42 | 206.53 | |
Free Cash Flow per Share |
24.21 | 23.80 | 25.55 | 22.01 | |
Free Cash Flow |
15,558.00 | 15,517.00 | 17,092.00 | 14,627.00 | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
23.16% | 21.99% | 24.40% | 21.00% | |
Accounts Receivable Turnover |
1.91 | 1.88 | 1.93 | 1.99 | |
Accounts Payable Turnover |
0.27 | 0.26 | 0.26 | 0.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,399.06 | 1,432.19 | 1,440.32 | 1,512.14 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.25) | (0.27) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.80% | 2.79% | 2.74% | 2.89% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.52 | 4.52 | 5.39 | 4.03 | |
Depreciation/Fixed assets |
— | — | 0.00 | — | |
Capex/Depreciation |
— | — | 0.00 | — | |
Revenue per Share |
123.57 | 119.00 | 115.24 | 108.22 | |
Operating CF per Share |
24.21 | 23.80 | 25.55 | 22.01 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
4.33% | 4.43% | 4.12% | 5.05% |
Columns are period end dates